A new fetal electrocardiogram (ECG) technology designed to be used along with conventional fetal heart rate monitoring contributes little benefit in reducing complications during childbirth, according to a study by the National Institutes of Health.
Northwestern University announced that it has received a five-year, $17.5 million grant from the National Institutes of Health to study an implantable drug delivery system for the prevention of HIV. It's the latest application of drug delivery to solve the classic medical problem of adherence by developing a device that releases medication in a continuous and controlled manner for up to one year.
The National Institutes of Health is offering funding to research initiatives that make use of the Cancer Genomics Cloud Pilots. The NIH is hoping the next wave of projects will help the National Cancer Institute decide how to establish computational infrastructure to support genomics research.
Investigators at the NIH have developed a new MERS vaccine that looks promising in mice. Focusing on the structure of a viral protein that the MERS virus uses to enter cells, the researchers developed a two-step, prime-boost process.
A vaccine against a wide range of flu viruses has long eluded scientists, but NIAID researchers have discovered what could be the foundation of a 'universal' flu vaccine.
Amid growing interest in innovative neurological devices to treat brain disorders, scientists supported by the National Institutes of Health (NIH) are developing a wireless, remote-controlled probe that could inject drugs and highlight neurons inside the brain.
Members of U.S. House of Representatives voted 344 to 77 today to approve the 21st Century Cures bill. It now goes to the Senate for consideration. The bill provides more funds for the FDA and NIH, but detractors are concerned about provisions that change the way drugs and devices are developed and approved.
Lawmakers in the House are expected to step up and cast their votes on the 21st Century Cures Act today, a big step toward once again shaking up the legal framework built to guide drug development in the U.S. while significantly boosting the amount of funding that flows to the NIH.
The mosquito-borne West Nile virus has infected more than 41,000 people and killed more than 1,700 people in the U.S. since 1999. But while there is an effective veterinary vaccine for the virus, there is no commercially available human vaccine. The National Institutes of Health's NIAID is launching a Phase I trial of a human vaccine at Duke University.
The National Institutes of Health has awarded more than $5 million over 5 years to diagnostics company Great Basin Scientific and Brigham Young University to develop a rapid molecular diagnostic test from whole blood for carbapenem-resistant Enterobacteriaceae (CRE).